These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20362738)

  • 21. Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease.
    Meco G; Bernardi S
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):311-3. PubMed ID: 16919377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [General practice study with atypical neuroleptics. Differences in tolerance].
    MMW Fortschr Med; 2002 May; Suppl 2():86. PubMed ID: 12070866
    [No Abstract]   [Full Text] [Related]  

  • 23. Serum prolactin, leptin, lipids and lipoproteins levels during antipsychotics treatment in Parkinson's disease and related psychosis.
    Rustembegovic A; Sofic E; Wichart I
    Med Arh; 2006; 60(4):211-2. PubMed ID: 16761509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Melperone is ineffective in treating Parkinson's disease psychosis.
    Friedman JH
    Mov Disord; 2012 May; 27(6):803-4. PubMed ID: 22362330
    [No Abstract]   [Full Text] [Related]  

  • 25. Quetiapine as treatment for dopaminergic-induced dyskinesias in Parkinson's disease.
    Baron MS; Dalton WB
    Mov Disord; 2003 Oct; 18(10):1208-9. PubMed ID: 14534933
    [No Abstract]   [Full Text] [Related]  

  • 26. Risperidone in levodopa-induced psychosis in advanced Parkinson's disease: an open-label, long-term study.
    Meco G; Alessandri A; Giustini P; Bonifati V
    Mov Disord; 1997 Jul; 12(4):610-2. PubMed ID: 9251085
    [No Abstract]   [Full Text] [Related]  

  • 27. A trial of quetiapine compared with risperidone in the treatment of first onset psychosis among 15- to 18-year-old adolescents.
    Swadi HS; Craig BJ; Pirwani NZ; Black VC; Buchan JC; Bobier CM
    Int Clin Psychopharmacol; 2010 Jan; 25(1):1-6. PubMed ID: 19809337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of quetiapine at low doses on psychosis motor disability and stress of the caregiver in patients with Parkinson's disease].
    Giménez-Roldán S; Navarro E; Mateo D
    Rev Neurol; 2003 Mar 1-15; 36(5):401-4. PubMed ID: 12640589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quetiapine treatment in early psychosis: no evidence of cataracts.
    Whitehorn D; Gallant J; Woodley H; Rui Q; Milliken H; Kopala L
    Schizophr Res; 2004 Dec; 71(2-3):511-2. PubMed ID: 15474924
    [No Abstract]   [Full Text] [Related]  

  • 30. Rhabdomyolysis after low-dose quetiapine in a patient with Parkinson's disease with drug-induced psychosis: a case report.
    Stephani C; Trenkwalder C
    Mov Disord; 2010 Apr; 25(6):790-1. PubMed ID: 20198646
    [No Abstract]   [Full Text] [Related]  

  • 31. Quetiapine-Induced extrapyramidal side effects in patients with Parkinson's disease: case report.
    Sommer BR
    J Geriatr Psychiatry Neurol; 2001; 14(2):99-100. PubMed ID: 11419575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiaggressive action of combined risperidone and quetiapine in a patient with schizophrenia.
    Bozikas VP; Deseri C; Pitsavas S; Karavatos A
    Can J Psychiatry; 2003 Jul; 48(6):426-7. PubMed ID: 12894620
    [No Abstract]   [Full Text] [Related]  

  • 33. Management of psychosis in Parkinson's disease.
    D'Souza C; Gupta A; Alldrick MD; Sastry BS
    Int J Clin Pract; 2003 May; 57(4):295-300. PubMed ID: 12800461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term outcome of quetiapine use for psychosis among Parkinsonian patients.
    Fernandez HH; Trieschmann ME; Burke MA; Jacques C; Friedman JH
    Mov Disord; 2003 May; 18(5):510-4. PubMed ID: 12722164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychosis in Parkinson's disease: how should we treat it?
    Shotbolt P; Samuel M; Anthony D
    Expert Rev Neurother; 2006 Sep; 6(9):1243-6. PubMed ID: 17009911
    [No Abstract]   [Full Text] [Related]  

  • 36. Repeated occurrence of clozapine-induced myocarditis in a patient with schizoaffective disorder and comorbid Parkinson's disease.
    Masopust J; Urban A; Valis M; Malý R; Tůma I; Hosák L
    Neuro Endocrinol Lett; 2009 Mar; 30(1):19-21. PubMed ID: 19300384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treating psychosis in Parkinson's disease with atypical antipsychotics.
    Duggal HS; Singh I
    Eur Psychiatry; 2005 Jan; 20(1):83-4. PubMed ID: 15642454
    [No Abstract]   [Full Text] [Related]  

  • 38. Psychosis in elderly patients: classification and pharmacotherapy.
    Mintzer J; Targum SD
    J Geriatr Psychiatry Neurol; 2003 Dec; 16(4):199-206. PubMed ID: 14653427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liquid risperidone in the treatment of psychotic agitation.
    Tsai C; Puzantian T
    CNS Drugs; 2002; 16(11):777; author reply 778. PubMed ID: 12383033
    [No Abstract]   [Full Text] [Related]  

  • 40. High dose quetiapine in the treatment of psychosis due to traumatic brain injury: a case report.
    Trémeau F; Mauro CJ; Shope C; Riber LM; Dhami S; Citrome L
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):280-1. PubMed ID: 20854867
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.